Intensive management can improve blood pressure in non-adherent hypertensive patients

Jul 07, 2009

Researchers from Boston University School of Medicine (BUSM) have shown that patients with uncontrolled hypertension respond to treatment intensification regardless of their degree of adherence to antihypertensive medications. This study, which has been published online in Hypertension could have an immediate impact on clinical care, as it challenges a widely held assumption.

The BUSM researchers studied 819 with . Adherence was assessed using electronic bottle caps that record all bottle openings and provide a detailed record of pill-taking. Patients were divided into five groups: those with the best adherence, next-best, fair, poor and patients who did not return their electronic bottle cap (missing adherence).

The investigators then characterized the degree to which each patient's therapy was intensified, relative to the patient's blood pressure control. The effect of treatment intensification upon the final blood pressure was similar in all five adherence groups, and the small differences among groups were not statistically significant. The investigators concluded that treatment intensification can improve control for patients with varying levels of adherence to therapy. .

"Despite a lack of evidence, many clinicians assume that 'nonadherent' patients cannot benefit from treatment intensification," said the study's lead author, Adam Rose, MD, MSc, an assistant professor of medicine at BUSM and investigator at the Bedford Veterans Administration Medical Center in Bedford Mass. "Our study calls this assumption into question. One of the major contributions of this study is to remind us that adherence is not a binary concept, with patients divided into those who are 'adherent' or 'nonadherent,'" added Rose.

Rose recommends further studies be undertaken to determine the most effective management strategy for patients with uncontrolled hypertension and suboptimal adherence.

Source: Boston University Medical Center

Explore further: Syria hit by flesh-eating maggot disease

add to favorites email to friend print save as pdf

Related Stories

New guidelines for treating resistant hypertension

Jun 06, 2008

Resistant hypertension, blood pressure that remains above goal despite taking three antihypertensive medications or high blood pressure that is controlled but requires four or more medications to do so, may benefit from specialized ...

Recommended for you

Syria hit by flesh-eating maggot disease

15 hours ago

Three cases of myiasis have been reported near Damascus, marking the first appearance of the flesh-eating maggot disease in Syria, UN health experts said Friday.

Sperm can carry Ebola for 82 days: WHO

17 hours ago

Sperm can carry the Ebola virus for at least 82 days, the World Health Organization said Friday, urging men recovering from the disease to use condoms for three months after the onset of symptoms.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.